Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature (Q40270911)
scientific article published on January 2006
Language:
Current Data About Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature
(P31) (Q13442814)
(P248)
(P698) 16757355
(P813) Tuesday, September 19, 2017

(P304) 597-612
(P248)
(P698) 16757355
(P813) Tuesday, September 19, 2017

(P407) (Q1860)

(P478) 407
(P248)
(P698) 16757355
(P813) Tuesday, September 19, 2017

(P577) Sunday, January 1, 2006
(P248)
(P698) 16757355
(P813) Tuesday, September 19, 2017

(P1433) (Q2076903)
(P248)
(P698) 16757355
(P813) Tuesday, September 19, 2017

(P1476) "Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature" (language: en)
(P248)
(P698) 16757355
(P813) Tuesday, September 19, 2017

(P2093) Lila Adnane
(P1545) 1
(P248)
(P698) 16757355
(P813) Tuesday, September 19, 2017

Pamela A Trail
(P1545) 2
(P248)
(P698) 16757355
(P813) Tuesday, September 19, 2017

Ian Taylor
(P1545) 3
(P248)
(P698) 16757355
(P813) Tuesday, September 19, 2017

Scott M Wilhelm
(P1545) 4
(P248)
(P698) 16757355
(P813) Tuesday, September 19, 2017

(P2860) (Q45077916)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q35581817)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q46242119)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q47807462)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q27860760)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q30736946)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q40543086)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q34660771)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q36069254)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q34946014)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q34376383)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q37097859)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q34543110)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q34160519)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q57281056)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q35935797)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q45186493)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q35968411)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q40444060)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q73144573)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q40459361)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q81307807)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q44263514)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q30736965)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q29617585)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

(Q33196532)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2907047-3
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published on January 2006

External Links
(P356) 10.1016/S0076-6879(05)07047-3
(P698) 16757355